Literature DB >> 29338700

Correction to: A systematic comparison of copy number alterations in four types of female cancer.

Fatemeh Kaveh1,2,3, Lars O Baumbusch1,3, Daniel Nebdal1, Anne-Lise Børresen-Dale1, Ole Christian Lingjærde1,4, Hege Edvardsen1, Vessela N Kristensen5,6, Hiroko K Solvang7.   

Abstract

After publication of the original article [1] the authors found that the article contained an incorrect version of Fig. 4. This does not affect the results and conclusions of the article.

Entities:  

Year:  2018        PMID: 29338700      PMCID: PMC5769487          DOI: 10.1186/s12885-017-3766-7

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


Correction

After publication of the original article [1] the authors found that the article contained an incorrect version of Fig. 4. This does not affect the results and conclusions of the article. An updated version of Fig. 4 is included with this Correction.
Fig. 4

Overlap between gene sets of four female cancer– Top biological functions. The Venn diagram displays joint genes identified by both, CBS and PCF algorithms located within the regions identified by GISTIC. The total number of genes for each data set is presented on the top right panel. Top biological functions and top canonical pathways for each region of the overlapped cancers are stated

Overlap between gene sets of four female cancer– Top biological functions. The Venn diagram displays joint genes identified by both, CBS and PCF algorithms located within the regions identified by GISTIC. The total number of genes for each data set is presented on the top right panel. Top biological functions and top canonical pathways for each region of the overlapped cancers are stated
  1 in total

1.  A systematic comparison of copy number alterations in four types of female cancer.

Authors:  Fatemeh Kaveh; Lars O Baumbusch; Daniel Nebdal; Anne-Lise Børresen-Dale; Ole Christian Lingjærde; Hege Edvardsen; Vessela N Kristensen; Hiroko K Solvang
Journal:  BMC Cancer       Date:  2016-11-22       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.